Cerium Oxide Nanoparticle Synthesis for Free Radical Scavenging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing cerium oxide nanoparticles for treating free radical damage are plagued by variability in particle size, surfactant toxicity, and agglomeration issues, leading to inconsistent efficacy and biological challenges.
Innovation Solution
The use of cerium oxide nanoparticles synthesized by methods other than the sol-gel process, such as those from Nanophase Technologies Corporation, which produce consistently sized particles with low agglomeration rates, enhancing their biological activity and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sol-gel process is used to produce cerium oxide nanoparticles, then free radical scavenging activity is achieved, but particle size control is poor and batch variability is high
Solution Approach 1:
The patent changes the synthesis parameters by switching from sol-gel process to alternative methods such as co-precipitation, hydrothermal synthesis, or microemulsion techniques. These methods allow precise control of particle size through parameters like pH, temperature, reaction time, and surfactant concentration, thereby achieving both reliable free radical scavenging activity and controlled particle size with reduced batch variability.
2Ease of manufacture
If sol-gel process is used to produce cerium oxide nanoparticles, then nanoparticles are formed, but surfactant tailing occurs causing toxicity and agglomeration
Solution Approach 1:
The patent extracts and removes surfactants from the final nanoparticle product through purification steps such as dialysis, centrifugation, or filtration after synthesis. This eliminates the harmful surfactant tailing effect while retaining the beneficial nanoparticle structure and free radical scavenging activity, thereby reducing toxicity and preventing agglomeration in biological media.
Solution Approach 2:
The patent uses alternative synthesis methods that employ different intermediaries or no surfactants at all. For example, co-precipitation uses controlled pH adjustment with buffers, while hydrothermal synthesis uses water as the reaction medium. These intermediary substances are easily removable or biocompatible, avoiding the persistence and toxicity issues associated with traditional surfactants.
3Reliability
If cerium oxide nanoparticles are placed in biological media, then biological effects are observed, but valence state changes occur over time
Solution Approach 1:
The patent performs preliminary stabilization of the cerium oxide nanoparticles before biological application. This includes pre-reduction or pre-oxidation treatments, surface coating with stabilizing agents, or storage under controlled atmospheric conditions to establish a desired Ce3+/Ce4+ ratio before the nanoparticles are introduced to biological media. This preliminary action locks in the valence state composition, preventing unwanted changes during subsequent biological experiments or treatments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These nanoparticles demonstrate improved reproducibility, reduced toxicity, and enhanced longevity by effectively scavenging free radicals, reducing inflammation, and providing radioprotective properties, extending cell and organism lifespan.
Implementation Method 1
The cerium oxide nanoparticles were proposed to act as free radical scavengers to bring about the observed results
Data Source
AI summary
The present invention provides cerium oxide nanoparticles for use both in therapeutic compositions in vivo and in research in vitro. The cerium oxide nanoparticles are of known range of sizes having biological properties that are reproducible and beneficial. Pharmaceutical and other compositions are provided, as are methods of treatment.